These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A national epidemiological study of Myasthenia Gravis in Australia. Gattellari M; Goumas C; Worthington JM Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211 [TBL] [Abstract][Full Text] [Related]
6. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa. Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of myasthenia gravis in Ontario, Canada. Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434 [TBL] [Abstract][Full Text] [Related]
9. The Epidemiology of Myasthenia Gravis in Korea. Lee HS; Lee HS; Shin HY; Choi YC; Kim SM Yonsei Med J; 2016 Mar; 57(2):419-25. PubMed ID: 26847295 [TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E; de Fine Olivarius B Neurology; 1993 Sep; 43(9):1779-83. PubMed ID: 8414031 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of myasthenia gravis in the province of Trento (northern Italy). Ferrari G; Lovaste MG Neuroepidemiology; 1992; 11(3):135-42. PubMed ID: 1407249 [TBL] [Abstract][Full Text] [Related]
13. A population based epidemiological study on myasthenia gravis in Estonia. Oöpik M; Kaasik AE; Jakobsen J J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1638-43. PubMed ID: 14638881 [TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis: a higher than expected incidence in the elderly. Aragonès JM; Bolíbar I; Bonfill X; Bufill E; Mummany A; Alonso F; Illa I Neurology; 2003 Mar; 60(6):1024-6. PubMed ID: 12654975 [TBL] [Abstract][Full Text] [Related]
15. A nationwide epidemiological study of myasthenia gravis in Latvia. Zieda A; Ravina K; Glazere I; Pelcere L; Naudina MS; Liepina L; Kamsa I; Kurjane N; Woodhall M; Jacobson L; Leite MI; Tandon K; Kenina V Eur J Neurol; 2018 Mar; 25(3):519-526. PubMed ID: 29194859 [TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Andersen JB; Heldal AT; Engeland A; Gilhus NE Acta Neurol Scand Suppl; 2014; (198):26-31. PubMed ID: 24588503 [TBL] [Abstract][Full Text] [Related]
17. [Myasthenia gravis. Register of 190 cases in a single center]. Aguirre F; Villa AM Medicina (B Aires); 2020; 80(1):10-16. PubMed ID: 32044736 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data. Keovilayhong S; Mulliez A; Feral L; Chenaf C; Clavelou P; Moisset X; Taithe F; Poncet Megemont L Rev Neurol (Paris); 2024 May; 180(5):451-458. PubMed ID: 38582663 [TBL] [Abstract][Full Text] [Related]
19. Three cases of myasthenia gravis from one family with variations in clinical features and serum antibodies. Chen Y; Wang W; Wei D; Yang L Neuromuscul Disord; 2012 Mar; 22(3):286-8. PubMed ID: 22082588 [TBL] [Abstract][Full Text] [Related]
20. MuSK antibody-positive, seronegative myasthenia gravis in Korea. Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]